Avanos Recalls Ballard Closed Suction Systems

Due to sterilization failure

May result in non-sterile devices

Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.

No injuries or deaths have been reported to date.

About the Device

The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.

Recommended Actions (as of March 19, 2025)

  • Immediately stop using any affected products and quarantine them.
  • Check your inventory for affected items listed in the recall notice.
  • Notify any customers or departments you may have shared the product with.
  • Complete and return the Response Form to: productquality@myairlife.com.
  • Arrange for return or confirm destruction of affected units to receive replacements.
  • Communicate the recall to all relevant staff within your organization.
  • For urgent replacement needs, contact AirLife at 1-800-433-2797.

Need Help?

For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.

Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.

Affected Products

Affected Product

Product Names:

  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
  • Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow 
  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
  • Ballard Closed Suction System for Adults, 14 F, T-Piece 
  • Ballard Closed Suction System for Adults, 14 F, DSE
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI 
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE

Click here to see a full list of affected devices.

Closing the Arterial Opening Without Surgery

Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following cardiovascular procedures.Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following...

FDA Approves Amplatzer Paraclose for Heart Valve Leaks

Abbott's Amplatzer Paraclose PVL Occluder offers a minimally invasive alternative for patients who develop a significant complication following heart valve replacement surgery.Heart valve replacement surgery can be lifesaving for patients with damaged or diseased...

October 2026 Premarket Approval (PMA) Authorizations

Three original device approvals and 218 supplements / noticesFDA's October activity highlights three newly approved medical devices and the extensive regulatory oversight required to maintain and modify products already on the market.The U.S. Food and Drug...